Patents by Inventor Daniela Monti

Daniela Monti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409630
    Abstract: The invention relates to topical ophthalmic preparations in eye drops containing bimatoprost as an active ingredient at the concentration of 0.1 mg/ml, wherein the presence of benzalkonium chloride is limited to the indispensable minimum commonly required for its activity as an antimicrobial preservative, i.e. from 50 at 80 ppm, and the bioavailability of the product is ensured by the addition of specific non-ionic surfactants, i.e., poloxamers.
    Type: Application
    Filed: November 2, 2020
    Publication date: December 29, 2022
    Inventors: Patrizia CHETONI, Susi BURGALASSI, Daniela MONTI, Silvia TAMPUCCI, Giulia FALCONE, Christina MATSIGKOU
  • Publication number: 20220233696
    Abstract: The present invention describes topical formulations for use in photodynamic therapy (PDT) of skin affections, said formulations comprising a Zn-phthalocyanine derivative.
    Type: Application
    Filed: March 6, 2020
    Publication date: July 28, 2022
    Inventors: Giacomo RONCUCCI, Lia FANTETTI, Annalisa COCCHI, Moira MUNICCHI, Francesco GIULIANI, Silvia TAMPUCCI, Daniela MONTI, Giacomo CHITI
  • Patent number: 8664197
    Abstract: Ophthalmic solutions containing arabinogalactans with a protective activity on the corneal epithelium, particularly suitable for use as artificial tears stimulating the recovery of corneal lesions and also particularly useful for contact lens users, containing from 1% to 10% by weight of arabinogalactan in an aqueous solution and possible other excipients, among which tonicity-adjusting agents, pH correctors, buffers and preservatives, except for benzalkonium chloride. The compositions according to the invention have a virtually negligible viscosity, but are sufficiently mucoadhesive to assure a considerable permanence time in the area of application. Besides being well-tolerated, the aforesaid compositions have considerable re-epithelization capacity.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: March 4, 2014
    Assignee: Opocrin S.p.A.
    Inventors: Patrizia Chetoni, Susi Burgalassi, Daniela Monti, Marco Fabrizio Saettone
  • Publication number: 20100160252
    Abstract: Ophthalmic solutions containing arabinogalactans with a protective activity on the corneal epithelium, particularly suitable for use as artificial tears stimulating the recovery of corneal lesions and also particularly useful for contact lens users, containing from 1% to 10% by weight of arabinogalactan in an aqueous solution and possible other excipients, among which tonicity-adjusting agents, pH correctors, buffers and preservatives, except for benzalkonium chloride. The compositions according to the invention have a virtually negligible viscosity, but are sufficiently mucoadhesive to assure a considerable permanence time in the area of application. Besides being well-tolerated, the aforesaid compositions have considerable re-epithelisation capacity.
    Type: Application
    Filed: August 10, 2006
    Publication date: June 24, 2010
    Inventors: Patrizia Chetoni, Susi Burgalassi, Daniela Monti, Marco Fabrizio Saettone